Skip to content

Comparison of posterior capsule opacification between 2 intraocular lenses in cataract patients associated with retinitis pigmentsa

Comparison of posterior capsule opacification between 2 intraocular lenses in cataract patients associated with retinitis pigmentsa - Posterior capsule opacification in patients with retinitis pigmentosa

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000023618
Enrollment
40
Registered
2016-09-01
Start date
2016-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract associated with patients with retinitis pigmentosa

Interventions

Cataract surgery and implantation of 1P intraocular lens (PCB00V) Cataract surgery and implantation of 3P intraocular lens (VA-70AD)

Sponsors

Kyushu University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who were more than 40 years-old 2. Patients who have cataract and retinitis pigmentosa 3. No prior intraocular surgery 4. Patients who are able to consent the study and cooperate in the examination after surgery. 5. No adverse events during cataract surgery 6. No severe systemic complications such as uncontrolled diabetes mellitus

Exclusion criteria

Exclusion criteria: 1. Patients who have ocular complications that can cause retinal abnormalities similar to retinitis pigmentsa 2. Patients who are in serious systemic conditions, including severe heart failure and uncontrolled diabetes mellitus. 3. Patients deemed inadequate for the study by the principal investigator

Design outcomes

Primary

MeasureTime frame
The severity of posterior capsule opacification evaluated by POCOman software at 1 year after cataract surgery

Secondary

MeasureTime frame
1) The severity and incidence of posterior capsule opacification evaluated by slit-lamp ophthalmoscope. 2) The severity of anterior capsule opacification, 3) The incidence of adverse events

Countries

Japan

Contacts

Public ContactYusuke Murakami

Kyushu University Hospital Dept of Ophthalmology

ymuraka3@med.kyushu-u.ac.jp092-642-5648

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026